Ring-closing metathesis process in supercritical fluid
    2.
    发明授权
    Ring-closing metathesis process in supercritical fluid 有权
    超临界流体闭环复分解过程

    公开(公告)号:US07189844B2

    公开(公告)日:2007-03-13

    申请号:US11222882

    申请日:2005-09-09

    IPC分类号: C07D245/00

    摘要: Disclosed is a process for preparing a compound of formula I comprising cyclizing a diene compound of formula III in the presence of a ruthenium catalyst in a suitable organic solvent, wherein the process is performed in a gaseous fluid at supercritical or near-supercritical conditions: The compounds of formula (I) are active agents for the treatment of hepatitis C viral (HCV) infections or are intermediates useful for the preparation of anti-HCV agents.

    摘要翻译: 公开了一种制备式I化合物的方法,其包括在钌催化剂存在下在合适的有机溶剂中使式III的二烯化合物环化,其中该方法在超临界或近超临界条件下在气态流体中进行: 式(I)化合物是用于治疗丙型肝炎病毒(HCV)感染的活性剂,或是可用于制备抗HCV药物的中间体。

    Ring-closing metathesis process in supercritical fluid
    6.
    发明申请
    Ring-closing metathesis process in supercritical fluid 有权
    超临界流体闭环复分解过程

    公开(公告)号:US20060063915A1

    公开(公告)日:2006-03-23

    申请号:US11222882

    申请日:2005-09-09

    IPC分类号: C07K5/12

    摘要: Disclosed is a process for preparing a compound of formula I comprising cyclizing a diene compound of formula III in the presence of a ruthenium catalyst in a suitable organic solvent, wherein the process is performed in a gaseous fluid at supercritical or near-supercritical conditions: The compounds of formula (I) are active agents for the treatment of hepatitis C viral (HCV) infections or are intermediates useful for the preparation of anti-HCV agents.

    摘要翻译: 公开了一种制备式I化合物的方法,其包括在钌催化剂存在下在合适的有机溶剂中环化式III的二烯化合物,其中该方法在超临界或近超临界条件下在气态流体中进行:

    Process of making di-aryl urea compounds
    10.
    发明授权
    Process of making di-aryl urea compounds 有权
    制备二芳基脲化合物的方法

    公开(公告)号:US07265222B2

    公开(公告)日:2007-09-04

    申请号:US10881589

    申请日:2004-06-30

    IPC分类号: C07D239/34

    摘要: Disclosed is a process of making compounds of formula(I): wherein R1, R2, R3, R4 and Ra of formula(I) are defined herein. The product compounds inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation. Also disclosed are intermediates useful in making such compounds.

    摘要翻译: 公开了制备式(I)化合物的方法:其中R 1,R 2,R 3,R 4, (I)的R a和R A在本文中定义。 产物化合物抑制涉及炎症过程的细胞因子的产生,因此可用于治疗涉及炎症的疾病和病理状况。 还公开了可用于制备这些化合物的中间体。